In the summer of 2012, Stryker implemented a voluntary recall of the Rejuvenate and ABG II hip replacement systems. They stated the devices presented “potential risks associated with modular-neck stems” that could lead to pain, swelling, tissue reactions, and premature hip implant failure. Since the
Boehringer Ingelheim, the manufacturer of blood-thinning drug Pradaxa, was recently fined nearly $1 million because it allegedly lost and destroyed important files. District Judge David Herndon, who is overseeing the coordinated Pradaxa lawsuits currently proceeding in the Southern District of Illin
Is testosterone therapy more of a benefit or risk for male patients? It’s a question once again under the microscope after a 2014 PLOS One study looked at the risk of acute non-fatal myocardial infarction (MI) after men were prescribed a form of testosterone therapy. …
On October 5, 2013, MLive news reported that a Flint, Michigan jury awarded a woman nearly $13 million in her lawsuit against Genesys Regional Medical Center. Libbey Bryson, 38 years old, claimed the medical center and its staff made critical mistakes during her delivery, causing…
On December 9, 2013, Vanity Fair ran an article titled, “Why is Potentially Lethal Contraceptive NuvaRing Still on the Market?” Currently, the manufacturer of the birth control device, Merck & Co., faces over 1,500 lawsuits filed by women claiming to have suffered serious injuries from…
On October 2, 2012, the U.S. Judicial Panel for Multidistrict Litigation (JPML) issued an order creating the Biomet Hip MDL. The order brought together all federal lawsuits with claims concerning the Biomet M2A-Magnum and Biomet M2A-38 hip replacement devices into the Northern District of Indiana.…
Shortly after the FDA approved the anti-coagulant “Pradaxa” in October 2010, patients started complaining of serious side effects. Prescribed to those with non-valvular atrial fibrillation to reduce risk of stroke, Pradaxa was hailed as the more convenient option to warfarin (Coumadin)—the leading a
In April 2013, the U.S. Judicial Panel on Multidistrict Litigation (JPML) issued an order centralizing all Tylenol personal injury lawsuits into one court in the Eastern District of Pennsylvania. The panel noted that they chose this location because McNeil Consumer Healthcare, the division of McNeil
On November 18, 2013, Bloomberg reported that Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson (J&J), was ordered by a Philadelphia jury to pay $11 million in a recent Topamax lawsuit. The plaintiffs claimed the anti-seizure drug caused their child to suffer from serious birth…
According to a press release from the Department of Justice, in May 2013, the “Medicare Fraud Strike Force charged 89 individuals, including doctors, nurses, and other licensed medical professionals, for their alleged participation in Medicare fraud schemes involving approximately $223 million in fa
In 2009, Florida resident Gary Townsend filed a nursing home lawsuit against Auburndale Oaks Healthcare Center in Auburndale, Florida. According to the Daily Mail, Townsend’s mother, Arlene, lived at the center from 2004 until her death in 2007. She was 69 years old. In the…
Back in July 2013, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all Stryker Rejuvenate and ABG II lawsuits into one court in the District of Minnesota. The consolidation was deemed appropriate because the lawsuits all involved common questions of fact and because the…